In contrast, transcriptomic data of pretreatment tumor tissues showed no significant enrichment of either IFN or APP signatures, suggesting that antitumor immunity is locally disturbed in the TME to support tumor progression (Fig 1 and S5 Table). This evidence concerns the gene IFNA1 and neoplasm.